ETRGF - Entourage Health Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0168
+0.0025 (+17.76%)
At close: 02:28PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0143
Open0.0167
BidN/A x N/A
AskN/A x N/A
Day's Range0.0139 - 0.0171
52 Week Range0.0138 - 0.0553
Volume40,560
Avg. Volume37,256
Market Cap5.169M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2800
Earnings DateAug 28, 2023 - Sep 01, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ETRGF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    Entourage Health Reports First Quarter 2023 Financial Results

    Total revenue of $15.1 million in Q1 2023 represents a 24% sequential increase over Q4 2022.Net Revenue in medical accounted for $6.0 million, a 61% sequential increase over Q4 2022.Color Cannabis captured a 5.3% national market share in the pre-roll segment.1Management will host a conference call on May 30, 2023, at 10 a.m. Eastern Time. TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and

  • GlobeNewswire

    Entourage Health to Host First Quarter 2023 Earnings Conference Call

    Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company announces issuance of 1,423,057 common shares from treasury in satisfaction of previously announced shares for debt transaction. TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced t

  • GlobeNewswire

    Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues

    The Company positions its 2023 business outlook to drive profitability and deliver enhanced premium product offerings, paving the way for long-term sustainabilityRecord net medical revenue of $17.4 million for 2022, representing 16% growthEntourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022Upsized credit facility with LiUNA Pension Fund Central and Eastern Canada (“LPF”) improves liquidity position TORONTO, May 01, 2023 (GLOBE NEWSWIRE)

  • GlobeNewswire

    Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results

    Company Financials for Full-Year 2022 to be filed by May 1, 2023.TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2022, by Monday, May 1, 2023. The Company will defer its fourth qua

  • GlobeNewswire

    Entourage Health Announces Timing of Fiscal Year End 2022 Conference Call for April 28

    Company financials to be filed after market on April 27, 2023, and operational outlook to be provided during call, including milestones achievedTORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended D

  • GlobeNewswire

    Entourage Health Corp Issues Deferred Share Units and Enters into Shares-for-Debt Agreements

    TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that, in accordance with the provisions of its omnibus equity incentive compensation plan (the “Omnibus Plan”), the Company has authorized the issuance of an aggregate of 1,600,000 deferred share units (“DSUs”) to non-management directors of the Company as compensation for

  • GlobeNewswire

    Entourage Health Continues to Expand Medical Offerings with Launch of CBD Chewing Gum and Signs New Union Group to the Starseed Medicinal Program

    Starseed continues to solidify its position as an industry leader leveraging its innovative medical cannabis products to include unique CBD chewing gumPlan administrator Union Benefits adds an additional union group and provides access to medical cannabis as an insured benefit TORONTO, March 27, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, is pleased t

  • CNW Group

    IIROC Trading Halt - ENTG.WT.A

    The following issues have been halted by IIROC:

  • GlobeNewswire

    Entourage Health Launches New Color Cannabis and Saturday Cannabis Products

    Introducing new cultivar, ‘Color Mint Cookie Kush;’ ‘Saturday 'Infused Pre-Rolls’ and ‘Saturday Motor Breath,’ a large format 28g flowerTORONTO, March 02, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce the expansion of its brand portfolio with new offerings. The Company's Color Cannabis and Saturday Cannabis adult-use pr

  • GlobeNewswire

    Entourage Health and LiUNA Pension Fund Close on $15M of Previously Announced Debt Financing

    Company also confirms it has signed an amended and restated credit agreement with LiUNATORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has successfully closed the second $15 million tranche of its upsized credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central and

  • GlobeNewswire

    Entourage Health's Color Cannabis Receives 2022 ADCANN Award for Canadian Marketing Campaign of the Year

    Consumer-facing cannabis awards recognize the brands' 'Just Add Color' marketing campaign as the best in 2022Company’s Chief People Officer resigning effective February 1, 2023 TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce Color Cannabis as a winner of the 2022 ADCANN Award for Canadian Marketing Campa

  • GlobeNewswire

    Entourage Health Updates Senior Secured Amended and Restated Credit Facility

    TORONTO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an amendment (the “Amendment”) to its senior secured amended and restated credit facility entered into on October 28, 2022 (the “Credit Facility”). The Amendment provides a waiver to the breach of certain financial covenants for the period ended September 30, 2022

  • GlobeNewswire

    Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue

    Company signs three-year supply agreement with HEXO Corp. to buy bulk cannabis for its expanding retail distribution and increased medical offeringsEntourage to transition away from cultivation as it phases out growing facilities, generating annualized cost savings of over $10 million and anticipated margin accretionSteadily improves capital structure with upsized credit facility for increased liquidityManagement to host conference call on November 15, 2022, at 10 a.m. Eastern Time TORONTO, Nov.

  • GlobeNewswire

    HEXO and Entourage Health Sign Long-Term Supply Agreement

    HEXO to provide bulk supply to Entourage over three-year period for multi-channel distributionThis news release constitutes a “designated news release” for the purposes of HEXO’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. GATINEAU, Quebec, Nov. 15, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO"), a leading producer of high-quality cannabis products, today announced the executio

  • GlobeNewswire

    Entourage Health to Host Third Quarter 2022 Financial Results Call on November 15

    TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its third quarter 2022 financial statements and management’s discussion and analysis after-market on Monday November 14, 2022. Entourage will host a conference call the following day on Tuesday, November 15, 2022 at 10 a.m. Eastern Time to review the results for th

  • GlobeNewswire

    Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $30 Million in Non-Dilutive Funding Availability

    Company also confirms it has signed an updated amended and restated credit agreement with senior lender, Bank of MontrealTORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has amended and upsized its existing credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central a

  • GlobeNewswire

    Entourage Launches New Suite of 15 Innovative Color Cannabis and Saturday Cannabis Products for its Largest Retail Product Call to Date

    Debuts: ‘Color Calendar’, a unique take on an adult-use Advent calendar featuring 24 pre-rolls; ‘Saturday Cranberry Sauce’ vape; ‘Color Live Resin Soft Chews’ and 'Color Infused Pre-Rolls'The Boston Beer Company’s cannabis-infused ‘TeaPot’ beverages arrive in Ontario, early Nov. TORONTO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products is pleased to

  • GlobeNewswire

    Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers

    Syndicate marketplace showcases a variety of specially curated products and formats made in-house and/or sourced from micro-cultivators looking for a medical distribution outletAs a supplemental market to insured benefits channel Starseed Medicinal, Syndicate will offer clients sans insurance access a variety of brand favourites including Color & Saturday Cannabis TORONTO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”

  • GlobeNewswire

    Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer

    New role optimizes resources in cultivation, production and supply chain for maximum outputTORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products is pleased to announce the appointment of James Afara as the Company’s Chief Operating Officer (COO). A results-driven leader with an exceptional track record, James brings over 15 years of operations a

  • GlobeNewswire

    Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program

    Plan administrator Union Benefits adds four union groups and six new southwestern Ontario locals, providing access to medical cannabis as an insured benefitTORONTO, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce its medical subsidiary Starseed Medicinal (“Starseed”) has added four new union groups to its full-service, propri

  • GlobeNewswire

    Entourage Health Reports Second Quarter 2022 Financial Results

    Management to host conference call on August 30, 2022, at 10 a.m. Eastern TimeTORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and six months ended June 30, 2022. The Company reported second quarter 2022 total revenue of $13.2 million and net revenue of $9.7 million, a slight total revenue

  • GlobeNewswire

    Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022

    Financial filings expected after-market August 29, with management conference call to follow next dayTORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its second quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, August 29, 2022. Entourage will host a conference call

  • GlobeNewswire

    Irwin Naturals Cannabis Products to Be Available in Canada

    Company announces licensing agreement with Entourage Brands for Canadian distribution of cannabis productsLOS ANGELES, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), whose herbal supplements are already available in in 100,000 stores in North America, has reached a licensing agreement with Entourage Health Corp. (TSX-V:ENT) (OTCQX:ETRGF) (FSE:4WE), a Canadian producer and distributor of award-winning cannabis products, throug

  • GlobeNewswire

    Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada

    Irwin-branded cannabis products will be first available to Starseed Medicinal patients in Q4 2022 Strategic nutraceuticals partnership follows recent release of recommendations for easing access to over-the-counter CBD-products in pharmacies TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products is pleased to announce it has entered into an exclus

  • GlobeNewswire

    Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures

    TORONTO, July 29, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has satisfied certain conditions in connection with the recent amendments to its existing senior secured credit facility entered into on March 29, 2019 (the “Senior Credit Facility”) between the Company and Bank of Montreal, and its existing second secured credit facility w